Tissue Historical Balance Sheet

TRX Stock

58.50 1.50 2.50%

Trend analysis of Tissue Regenix Group balance sheet accounts such as Other Stockholder Equity of 186.4 M, Total Liab of 16.8 M, Common Stock of 99.4 K or Common Stock Shares Outstanding of 80.5 M provides information on Tissue Regenix's total assets, liabilities, and equity, which is the actual value of Tissue Regenix Group to its prevalent stockholders. By breaking down trends over time using Tissue Regenix balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Tissue Regenix Group latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Tissue Regenix Group is a good buy for the upcoming year.

Tissue Regenix Inventory

12.51 Million

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tissue Regenix Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

About Tissue Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Tissue Regenix Group at a specified time, usually calculated after every quarter, six months, or one year. Tissue Regenix Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Tissue Regenix and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Tissue currently owns. An asset can also be divided into two categories, current and non-current.

Tissue Regenix Balance Sheet Chart

At present, Tissue Regenix's Other Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Total Liabilities is expected to grow to about 16.8 M, whereas Total Stockholder Equity is forecasted to decline to about 25.9 M.

Total Assets Total Stockholder Equity Common Stock Total Equity Other Stockholder Equity

Add Fundamental

Total Assets

Total assets refers to the total amount of Tissue Regenix assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Tissue Regenix Group books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Common Stock Total Equity

The total value of common stock equity held by shareholders, representing their ownership interest in the company.

Most accounts from Tissue Regenix's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Tissue Regenix Group current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tissue Regenix Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

	2022	2023	2024	2025 (projected)
Total Stockholder Equity	26.0M	30.2M	34.7M	25.9M
Total Assets	38.3M	43.2M	49.7M	30.2M

Total Stockholder Equity Total Assets

Tissue Regenix balance sheet Correlations

	Total Assets	Total Stockholder Equity	Other Assets	Common Stock Total Equity	Other Stockholder Equity	Total Liab	Common Stock	Common Stock Shares Outstanding	Other Current Liab	Total Current Liabilities	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Good Will	Non Current Liabilities Total	Other Current Assets	Property Plant And Equipment Gross	Total Current Assets	Intangible Assets	Property Plant Equipment
Total Assets		0.93	-0.42	0.45	0.55	0.48	0.19	-0.37	0.52	0.57	0.44	-0.12	-0.56	0.45	0.26	0.47	-0.19	0.26	0.33	0.24	0.37	0.36	0.38	0.59	0.36	0.42
Total Stockholder Equity	0.93		-0.22	0.16	0.31	0.18	0.15	-0.4	0.32	0.32	0.15	-0.44	-0.26	0.24	0.55	0.22	-0.44	0.55	0.1	0.42	0.08	0.18	0.1	0.78	0.33	0.12
Other Assets	-0.42	-0.22		-0.7	-0.79	-0.79	0.52	0.03	-0.32	-0.62	-0.81	-0.45	0.77	-0.23	0.29	-0.6	-0.34	0.29	-0.11	0.14	-0.84	-0.9	-0.88	-0.06	0.3	-0.73
Common Stock Total Equity	0.45	0.16	-0.7		0.87	0.96	0.15	0.05	0.48	0.83	0.96	0.7	-0.93	0.65	-0.56	0.8	0.47	-0.56	0.63	-0.38	0.94	0.72	0.92	-0.16	0.1	0.97
Other Stockholder Equity	0.55	0.31	-0.79	0.87		0.94	-0.09	-0.08	0.65	0.94	0.9	0.63	-0.93	0.56	-0.5	0.88	0.36	-0.5	0.6	-0.08	0.87	0.76	0.88	-0.11	0.24	0.86
Total Liab	0.48	0.18	-0.79	0.96	0.94		-0.02	-0.08	0.57	0.89	0.99	0.73	-0.95	0.57	-0.58	0.88	0.51	-0.58	0.57	-0.39	0.97	0.79	0.96	-0.17	0.11	0.98
Common Stock	0.19	0.15	0.52	0.15	-0.09	-0.02		-0.08	0.16	0.07	-0.05	-0.05	-0.06	0.44	0.05	-0.01	-0.1	0.05	0.52	-0.03	-0.09	-0.43	-0.21	0.06	0.52	0.07
Common Stock Shares Outstanding	-0.37	-0.4	0.03	0.05	-0.08	-0.08	-0.08		0.0	-0.05	-0.06	0.15	0.05	-0.07	-0.19	-0.17	0.03	-0.19	0.15	0.12	-0.03	-0.06	0.03	-0.26	-0.33	-0.05
Other Current Liab	0.52	0.32	-0.32	0.48	0.65	0.57	0.16	0.0		0.81	0.5	0.37	-0.6	0.25	-0.32	0.61	0.24	-0.32	0.63	0.12	0.41	0.34	0.43	-0.08	0.43	0.48
Total Current Liabilities	0.57	0.32	-0.62	0.83	0.94	0.89	0.07	-0.05	0.81		0.85	0.62	-0.89	0.58	-0.52	0.9	0.41	-0.52	0.73	-0.1	0.77	0.64	0.8	-0.15	0.39	0.83
Property Plant And Equipment Net	0.44	0.15	-0.81	0.96	0.9	0.99	-0.05	-0.06	0.5	0.85		0.72	-0.94	0.56	-0.57	0.85	0.53	-0.57	0.51	-0.44	0.98	0.82	0.98	-0.17	0.03	0.99
Net Debt	-0.12	-0.44	-0.45	0.7	0.63	0.73	-0.05	0.15	0.37	0.62	0.72		-0.67	0.49	-0.98	0.75	0.73	-0.98	0.59	-0.52	0.71	0.5	0.71	-0.8	0.17	0.74
Retained Earnings	-0.56	-0.26	0.77	-0.93	-0.93	-0.95	-0.06	0.05	-0.6	-0.89	-0.94	-0.67		-0.65	0.53	-0.85	-0.5	0.53	-0.63	0.24	-0.91	-0.74	-0.9	0.13	-0.17	-0.93
Accounts Payable	0.45	0.24	-0.23	0.65	0.56	0.57	0.44	-0.07	0.25	0.58	0.56	0.49	-0.65		-0.44	0.65	0.28	-0.44	0.77	-0.13	0.5	0.2	0.48	-0.21	0.52	0.63
Cash	0.26	0.55	0.29	-0.56	-0.5	-0.58	0.05	-0.19	-0.32	-0.52	-0.57	-0.98	0.53	-0.44		-0.67	-0.72	1.0	-0.58	0.47	-0.55	-0.36	-0.55	0.9	-0.22	-0.59
Non Current Assets Total	0.47	0.22	-0.6	0.8	0.88	0.88	-0.01	-0.17	0.61	0.9	0.85	0.75	-0.85	0.65	-0.67		0.47	-0.67	0.67	-0.28	0.76	0.64	0.79	-0.34	0.48	0.83
Non Currrent Assets Other	-0.19	-0.44	-0.34	0.47	0.36	0.51	-0.1	0.03	0.24	0.41	0.53	0.73	-0.5	0.28	-0.72	0.47		-0.72	0.35	-0.54	0.52	0.45	0.52	-0.6	-0.03	0.53
Cash And Short Term Investments	0.26	0.55	0.29	-0.56	-0.5	-0.58	0.05	-0.19	-0.32	-0.52	-0.57	-0.98	0.53	-0.44	1.0	-0.67	-0.72		-0.58	0.47	-0.55	-0.36	-0.55	0.9	-0.22	-0.59
Net Receivables	0.33	0.1	-0.11	0.63	0.6	0.57	0.52	0.15	0.63	0.73	0.51	0.59	-0.63	0.77	-0.58	0.67	0.35	-0.58		-0.01	0.44	0.07	0.4	-0.37	0.64	0.56
Good Will	0.24	0.42	0.14	-0.38	-0.08	-0.39	-0.03	0.12	0.12	-0.1	-0.44	-0.52	0.24	-0.13	0.47	-0.28	-0.54	0.47	-0.01		-0.46	-0.25	-0.42	0.39	0.24	-0.48
Non Current Liabilities Total	0.37	0.08	-0.84	0.94	0.87	0.97	-0.09	-0.03	0.41	0.77	0.98	0.71	-0.91	0.5	-0.55	0.76	0.52	-0.55	0.44	-0.46		0.81	0.98	-0.16	-0.11	0.96
Other Current Assets	0.36	0.18	-0.9	0.72	0.76	0.79	-0.43	-0.06	0.34	0.64	0.82	0.5	-0.74	0.2	-0.36	0.64	0.45	-0.36	0.07	-0.25	0.81		0.87	-0.02	-0.22	0.75
Property Plant And Equipment Gross	0.38	0.1	-0.88	0.92	0.88	0.96	-0.21	0.03	0.43	0.8	0.98	0.71	-0.9	0.48	-0.55	0.79	0.52	-0.55	0.4	-0.42	0.98	0.87		-0.17	-0.11	0.96
Total Current Assets	0.59	0.78	-0.06	-0.16	-0.11	-0.17	0.06	-0.26	-0.08	-0.15	-0.17	-0.8	0.13	-0.21	0.9	-0.34	-0.6	0.9	-0.37	0.39	-0.16	-0.02	-0.17		-0.19	-0.2
Intangible Assets	0.36	0.33	0.3	0.1	0.24	0.11	0.52	-0.33	0.43	0.39	0.03	0.17	-0.17	0.52	-0.22	0.48	-0.03	-0.22	0.64	0.24	-0.11	-0.22	-0.11	-0.19		0.07
Property Plant Equipment	0.42	0.12	-0.73	0.97	0.86	0.98	0.07	-0.05	0.48	0.83	0.99	0.74	-0.93	0.63	-0.59	0.83	0.53	-0.59	0.56	-0.48	0.96	0.75	0.96	-0.2	0.07

Click cells to compare fundamentals

Tissue Regenix Account Relationship Matchups

Tissue Regenix balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	36.7M	34.1M	38.3M	43.2M	49.7M	30.2M
Total Stockholder Equity	28.5M	25.4M	26.0M	30.2M	34.7M	25.9M
Liabilities And Stockholders Equity	36.7M	34.1M	38.3M	43.2M	49.7M	30.3M
Other Stockholder Equity	93.5M	98.1M	138.9M	154.4M	177.5M	186.4M
Total Liab	8.9M	9.5M	13.0M	13.9M	16.0M	16.8M
Common Stock	11.7M	11.8M	13.3M	91K	104.7K	99.4K
Common Stock Shares Outstanding	44.5M	70.3M	70.3M	70.4M	81.0M	80.5M
Other Current Liab	1.4M	477.5K	4.4M	2.6M	3.0M	1.6M
Total Current Liabilities	3.3M	3.2M	5.5M	4.7M	5.4M	5.7M
Property Plant And Equipment Net	5.7M	6.7M	7.4M	9.0M	10.4M	10.9M
Net Debt	(4.2M)	175.7K	3.0M	4.7M	5.5M	5.7M
Retained Earnings	(77.7M)	(84.7M)	(96.8M)	(123.8M)	(111.4M)	(105.8M)
Accounts Payable	1.3M	2.6M	1.1M	1.2M	1.4M	921.0K
Cash	9.6M	5.7M	4.9M	4.7M	4.2M	4.0M
Non Current Assets Total	16.6M	17.8M	20.0M	24.2M	27.8M	29.2M
Non Currrent Assets Other	(8.6M)	(8.6M)	(9.6M)	(5.2M)	(6.0M)	(6.3M)
Cash And Short Term Investments	9.6M	5.7M	4.9M	4.7M	4.2M	4.0M
Net Receivables	3.5M	3.4M	4.3M	2.4M	2.7M	2.1M
Good Will	8.6M	8.6M	9.6M	11.6M	10.4M	9.1M
Non Current Liabilities Total	5.6M	6.3M	7.5M	9.2M	10.5M	11.1M
Other Current Assets	1.7M	1.2M	834.7K	4.1M	4.7M	4.9M
Property Plant And Equipment Gross	5.7M	9.1M	8.9M	14.4M	16.6M	17.4M
Total Current Assets	20.1M	16.3M	18.3M	19.1M	22.0M	20.8M
Accumulated Other Comprehensive Income	955K	197.9K	(942.7K)	(529.5K)	(608.9K)	(639.4K)
Intangible Assets	10.9M	11.1M	12.5M	3.5M	4.1M	3.9M
Property Plant Equipment	2.4M	5.7M	9.1M	8.9M	10.3M	10.8M
Net Tangible Assets	7.2M	17.7M	19.3M	17.6M	20.2M	17.7M
Inventory	7.1M	7.2M	9.0M	10.4M	11.9M	12.5M
Other Liab	670K	560K	640K	520K	468K	618.7K
Net Invested Capital	31.3M	38.8M	37.5M	36.1M	41.6M	38.4M
Net Working Capital	16.8M	17.7M	15.4M	14.4M	16.5M	15.8M
Capital Stock	9.6M	9.2M	9.2M	91K	81.9K	77.8K
Short Long Term Debt Total	5.3M	5.9M	8.0M	9.4M	10.8M	6.8M
Long Term Debt	2.8M	4.5M	5.3M	5.5M	6.4M	4.4M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

BTC	Bitcoin
TRX	TRON
BNB	Binance Coin

Other Information on Investing in Tissue Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Tissue Historical Balance Sheet

Tissue Regenix Inventory

12.51 Million

About Tissue Balance Sheet Analysis

Tissue Regenix Balance Sheet Chart

Total Assets

Total Stockholder Equity

Common Stock Total Equity

Tissue Regenix balance sheet Correlations

Tissue Regenix Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Tissue Regenix balance sheet Accounts

Also Currently Popular

Other Information on Investing in Tissue Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Property Plant And Equipment Net	+ 0.99	Total Liab
Property Plant Equipment	+ 0.99	Property Plant And Equipment Net
Property Plant Equipment	+ 0.98	Total Liab
Non Current Liabilities Total	+ 0.98	Property Plant And Equipment Net
Property Plant And Equipment Gross	+ 0.98	Property Plant And Equipment Net

Cash And Short Term Investments	- 0.98	Net Debt
Cash	- 0.98	Net Debt
Retained Earnings	- 0.95	Total Liab
Retained Earnings	- 0.94	Property Plant And Equipment Net
Property Plant Equipment	- 0.93	Retained Earnings
Retained Earnings	- 0.93	Other Stockholder Equity